# iShares Silver Trust: overview SLV · NYSE · CIK 1330568 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/slv.md) · [Financials](/companies/slv/financials.md) · [Filings](/companies/slv/filings.md) · [Insiders](/companies/slv/insiders.md) Latest reported revenue: [−$730.5m](/filings/0001437749-16-026351.md) for Q4 FY2013, three months to 2013-12-31, from the 10-K filed Feb 29, 2016 (XBRL us-gaap:Revenues, accession 0001437749-16-026351). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/slv/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $2.56bn | 47,849,100 | Call | Reduced −4,229,900 | | [CTC LLC](/funds/1445893.md) | 2026-06-30 | $2.21bn | 413,495 | Put | Reduced −197,590 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $1.88bn | 35,138,500 | Put | Reduced −9,967,400 | | [CTC LLC](/funds/1445893.md) | 2026-06-30 | $1.76bn | 329,176 | Call | Reduced −147,903 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $1.72bn | 32,226,600 | Call | Reduced −23,365,200 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $1.68bn | 31,327,400 | Call | Reduced −15,166,900 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $1.42bn | 26,650,300 | Put | Reduced −6,390,600 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $799.8m | 14,958,700 | Put | Reduced −14,681,000 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $720.4m | 13,473,698 | | Added +1,248,173 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $560.1m | 10,475,933 | | Added +804,961 | ## Recent filings [All 215 filings](/companies/slv/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-06 | 19:38 ET | [10-Q](/filings/0001437749-26-026005.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026005 | | 2026-05-07 | 15:43 ET | [10-Q](/filings/0001437749-26-015539.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015539 | | 2026-03-31 | 21:49 ET | [8-K](/filings/0001437749-26-010478.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-010478 | | 2026-02-27 | 13:44 ET | [10-K](/filings/0001437749-26-006059.md) | Annual report, period 2025-12-31 | 0001437749-26-006059 | | 2025-11-06 | 21:11 ET | [10-Q](/filings/0001437749-25-033436.md) | Quarterly report, period 2025-09-30 | 0001437749-25-033436 | | 2025-08-05 | 16:50 ET | [10-Q](/filings/0001437749-25-024885.md) | Quarterly report, period 2025-06-30 | 0001437749-25-024885 | | 2025-05-07 | 17:08 ET | [10-Q](/filings/0001437749-25-015169.md) | Quarterly report, period 2025-03-31 | 0001437749-25-015169 | | 2025-02-19 | 17:41 ET | [10-K](/filings/0001437749-25-004259.md) | Annual report, period 2024-12-31 | 0001437749-25-004259 | | 2024-11-07 | 11:37 ET | [10-Q](/filings/0001437749-24-033818.md) | Quarterly report, period 2024-09-30 | 0001437749-24-033818 | | 2024-08-08 | 12:24 ET | [10-Q](/filings/0001437749-24-025404.md) | Quarterly report, period 2024-06-30 | 0001437749-24-025404 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-006059.md), filed Feb 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1330568 - Tickers: SLV - Exchange: NYSE - SIC code: 6221 Commodity Contracts Brokers & Dealers - State of incorporation: NY - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.